Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 12
Submit an article Journal homepage
466
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Primary refractory multiple myeloma: a real-world experience with 85 cases

Artur Jurczyszyna Department of Hematology, Jagiellonian University Medical College, Cracow, PolandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9796-8365
ORCID Icon,
Anna Waszczuk-Gajdab Department of Hematology, Oncology and Internal Medicine, Warsaw Medical University, Warsaw, PolandORCID Iconhttps://orcid.org/0000-0001-5626-1750
ORCID Icon,
Jorge J. Castilloc Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0001-9490-7532
ORCID Icon,
Katarzyna Krawczyka Department of Hematology, Jagiellonian University Medical College, Cracow, Poland
,
Martin Storkd Department of Internal Medicine, Hematology and Oncology, University Hospital, Brno, Czech Republic
,
Ludek Pourd Department of Internal Medicine, Hematology and Oncology, University Hospital, Brno, Czech Republic
,
Lidia Usnarska-Zubkiewicze Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
,
Stanisław Potoczeke Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
,
Iwona Husf Medical University of Lublin, LublinPoland
,
Julio Davila Vallsg Complejo Asistencial de Avila, Avila, Spain
,
Parameswaran Harih Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
,
Saurabh Chhabrah Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
,
Massimo Gentilei Hematology Unit of Cosenza, Italy
,
Gabor Mikalaj Department of Hematology and Stem Cell Transplantation, South-Pest Central Hospital, National Institute of Hematology and Infectology, Budapest, Hungary;
,
Gergely Vargak 3 Department of Internal Medicine, Semmelweis University, Budapest, HungaryORCID Iconhttps://orcid.org/0000-0001-6875-056X
ORCID Icon,
Chor Sang Chiml Division of Hematology and Medical Oncology, Queen Mary Hospital, Hong Kong, ChinaORCID Iconhttps://orcid.org/0000-0003-2427-915X
ORCID Icon,
Mark Fialam Washington University School of Medicine, St. Louis, MS, USA
,
Ravi Vijm Washington University School of Medicine, St. Louis, MS, USA
,
Natalia Schutzn Department of Internal Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
,
Marek Rodzajo Department of Hematology, Regional Specialistic Hospital, Cracow, Poland
,
Agnieszka Porowskap Department of Oncology and Haematology, Central Clinical Hospital of the Ministry of the Interior, Warsaw, Poland
,
David H. Vesoleq John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA
,
Agnieszka Druzd-Sitekr Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
,
Jan Walewskir Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
&
Ajay K. Nookas School of Medicine, Emory University, Atlanta, GA, USA
 show all
Pages 2868-2875 | Received 09 Apr 2020, Accepted 19 Jun 2020, Published online: 05 Jul 2020

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sergio Giralt. (2020) Primary refractory multiple myeloma – what role for high dose melphalan?. Leukemia & Lymphoma 61:12, pages 2785-2785.
Read now

Articles from other publishers (4)

Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, Moritz Binder, Francis K. Buadi, Joselle Cook, David Dingli, Angela Dispenzieri, Amie L. Fonder, Morie A. Gertz, Wilson Gonsalves, Suzanne R. Hayman, Miriam A. Hobbs, Yi L. Hwa, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar & Shaji K. Kumar. (2023) Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy. Blood Advances 7:16, pages 4371-4380.
Crossref
Virág Réka Szita, Ádám Wiedemann, Szabolcs Syoreni, András Tóth, Eszter Ruff, Lilla Gaál, Tamás Masszi & Gergely Varga. (2023) Venetoclaxalapú mentőkezelés (11;14)-transzlokációs myeloma multiplexben az első vonalbeli kezelésre adott nem megfelelő válasz esetén. Orvosi Hetilap 164:23, pages 894-899.
Crossref
Virág Réka Szita, Gábor Mikala, András Kozma, János Fábián, Apor Hardi, Hussain Alizadeh, Péter Rajnics, László Rejtő, Tamás Szendrei, László Váróczy, Zsolt Nagy, Árpád Illés, István Vályi-Nagy, Tamás Masszi & Gergely Varga. (2022) Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers. Pathology and Oncology Research 28.
Crossref
Meera Mohan, Aniko Szabo, Naveen Yarlagadda, Sravani Gundarlapalli, Sharmilan Thanendrarajan, Samantha Kendrick, Carolina Schinke, Daisy Alapat, Jeffrey Sawyer, Erming Tian, Guido Tricot, Frits Rhee & Maurizio Zangari. (2021) Persistent bone marrow minimal residual disease as a “high‐risk” disease feature in multiple myeloma. American Journal of Hematology 96:9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.